FDA-LogoPresentation to FDA on Mefloquine Neurotoxicity, Dr. Remington Nevin,

January 11, 2013.

Soldier Prescribed Controversial Anti-Malarial Drug Before Afghan Massacre, KPBS public broadcasting, San Diego,  By  Beth Ford Roth, July 15, 2013.  

logo-home-200Sunday Times : Letters link drug to army rampage, (London. Irish edition], Mark Tighe, 14 July 2013

timelogo The Sergeant-Lariam Link Seems to Grow Stronger
July 8, 2013


Lariam product update from Ireland — strongest product information in the world  to date. 17 June 2013
Psychiatric Side Effects of Mefloquine: Applications to Forensic Psychiatry, by  Elspeth Cameron Ritchie, MD, MPH,Jerald Block, MD and Remington Lee Nevin, MD, MPH, Journal of the American Academy of Psychiatry and the Law Online, June 14, 2013

FDA-Logo FDA Potential Signals of Serious Risks/New Safety Information Identified by the Adverse Event Reporting System (AERS) between April – June 2012. “Potential signal of a serious risk/new safety information”: Mefloquine listed for vestibular disorders.

RTÉ Investigations Unit Prime Time report by Rita O’Reilly on Lariam’s link to suicides in the Irish Defence Forces, May 23, 2013.

View the RTE Investigations Unit Prime Time blog

Malaria Medicine Could Be Toxic. Tia Ghose, Live Science, May 22, 2013

Potential Signals of Serious Risks/New Safety Information Identified by the Adverse Event Reporting System (AERS) between April – June 2012. Mefloquine HCL (Lariam): Vestibular disorder. FDA is continuing to evaluate this issue to determine the need for any regulatory action.

Time A Potential Therapy for PTSD?    by Remington Nevin, MD. “The effects of PTSD, TBI, and now mefloquine toxicity, need to be considered together – as the three signature injuries of modern war.” Feb. 13, 2013.

The Lariam Debate . . . Continues, by Mark Thompson, Time.com, Dec. 5, 2012.

va-sealUS Department of Veterans Affairs: Deployment Exposures – War Related Illness and Injury Study Center (WRIISC).  Mefloquine (Lariam) is listed with war-related agents such as Agent Orange, Burn Pits, Ionizing Radiation, and more.

Voice Mefloquine Toxicity: Listen in on a live discussion with Dr Remington Nevin, CDR Bill Manofsky USN Ret., and others. Voice of Warriors / BlogTalk Radio, Nov. 27, 2012

Warnings about psychological side effects of malaria drug Lariam grow louder NewsWorks, September 12, 2012

Committee on Appropriations logo WEBCAST: Request to Senate Appropriations Subcommittee to fund research on mefloquine June 6, 2012

Documents Uncovered by Judicial Watch Raise Concerns About Use of Drug for Military PersonnelJudicial Watch, May 2, 2012.

Democracy Now logoPentagon Stays Silent on Whether Suspect in Afghan Massacre Took Controversial Anti-Malaria DrugDemocracy Now, March 27, 2012.

White paper Mefloquine Neurotoxicity: PTSD, Traumatic Brain Injury, and Mental Illness in DoD. Remington Nevin MD MPH, 2012

you tube logoNeuropsychiatric Adverse Events Associated with Mefloquine. Dr. Remington Nevin reviews recent research on the epidemiology and pathophysiology of mefloquine neuropsychiatric side effects. Special Operations Medical Association conference, Tampa, FL, Dec. 16, 2011.

United State's Senate Logo Senator Dianne Feinstein Calls for Review of Anti-malarial Drug. August 18, 2011

Seton Hall Law Report Shows U.S. Military Routinely Administered Controversial Drugs to Detainees in Guantanamo Bay (press release).

Mass administration of the antimalarial drug mefloquine to Guantanamo detainees: a critical analysis. 2012. For information contact rnevin@jhsph.edu

JRSM logo“A Lesson Learnt: the rise and fall of Lariam and Halfan,” by Dr Ashley Croft, Journal of the Royal Society of Medicine, April 2007. This essay looks at the unusual developmental history of Lariam and Halfan, explains the circumstances under which both drugs rose in esteem with policy makers and prescribers and then fell into disfavour with consumers, and summarizes the lessons learnt in the process.

Soldiers committing suicide, by Jason Notte, The Phoenix.com, 2009

 August 2009: Lariam (mefloquine), manufactured by Roche Pharmaceuticals, is no longer sold under that trade name in the United States. Generic mefloquine, however, is widely available.